• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺细胞病理学报告的贝塞斯达系统诊断类别的组织病理学回顾——五年机构经验

Histopathological Review of Diagnostic Categories of the Bethesda System for Reporting Thyroid Cytopathology - An Institutional Experience of 5 Years.

作者信息

Upadhyaya Paricha, Dhakal Sushil, Adhikari Purbesh, Adhikari Bindu, Khadka Dibika, Niraula Surya R

机构信息

Department of Pathology, BP Koirala Institute of Health Sciences, Karnali Province, Nepal.

Department of Pathology, Province Hospital, Karnali Province, Nepal.

出版信息

J Cytol. 2019 Jan-Mar;36(1):48-52. doi: 10.4103/JOC.JOC_64_18.

DOI:10.4103/JOC.JOC_64_18
PMID:30745740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6343391/
Abstract

CONTEXT

Fine needle aspiration (FNA) plays a crucial role in the evaluation of patients with thyroid lesions. The Bethesda system for reporting thyroid cytopathology (TBSRTC) was designed with a mission to standardize the process of diagnosis and management of thyroid lesions by FNA cytology (FNAC).

AIM

We aim to see the benefits of adopting TBSRTC, seek the cytological pitfalls in the diagnosis of thyroid FNAC, and identify the spectrum of thyroid lesions in our setup.

SETTINGS AND DESIGN

This is a hospital-based cross-sectional study conducted from June 2009 to June 2014 of all thyroid FNACs with available histopathology reports. Cases were designated a specific diagnostic category according to TBSRTC.

MATERIALS AND METHODS

A total of 109 cases were included in the study. Sixty-eight cases had been reported without using TBSRTC and were reviewed and reclassified according to TBSRTC seeking the common reasons for interpretative errors.

STATISTICAL ANALYSIS USED

Data were analyzed using SPSS ver. 11.5.

RESULTS

In both pre- and post-TBSRTC era, benign neoplasms constituted the major bulk. After the use of TBSRTC, there was increased ability to look for follicular neoplasms, improvement in making definitive diagnosis of the cases, decline in the suspicious category, and an improvement in diagnostic accuracy, and we were in line with the implied risk outlined by TBSRTC in most of the cases except the nondiagnostic or unsatisfactory category.

CONCLUSION

Application of TBSRTC results in uniformity in reporting among pathologists and better interdisciplinary communication and patient management.

摘要

背景

细针穿刺抽吸活检(FNA)在甲状腺病变患者的评估中起着至关重要的作用。甲状腺细胞病理学报告的贝塞斯达系统(TBSRTC)旨在通过FNA细胞学(FNAC)规范甲状腺病变的诊断和管理过程。

目的

我们旨在观察采用TBSRTC的益处,寻找甲状腺FNAC诊断中的细胞学陷阱,并确定我们机构中甲状腺病变的范围。

设置与设计

这是一项基于医院的横断面研究,于2009年6月至2014年6月对所有有可用组织病理学报告的甲状腺FNAC病例进行。根据TBSRTC将病例指定为特定的诊断类别。

材料与方法

本研究共纳入109例病例。68例病例在报告时未使用TBSRTC,根据TBSRTC进行回顾和重新分类,以寻找解释性错误的常见原因。

所用统计分析方法

使用SPSS 11.5版软件进行数据分析。

结果

在TBSRTC应用前后,良性肿瘤均占主要部分。使用TBSRTC后,寻找滤泡性肿瘤的能力增强,病例确诊率提高,可疑类别减少,诊断准确性提高,除无法诊断或不满意类别外,大多数病例符合TBSRTC所暗示的风险。

结论

应用TBSRTC可使病理学家之间的报告趋于一致,改善多学科沟通和患者管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef1/6343391/4a8163e5e3cc/JCytol-36-48-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef1/6343391/bf0725d49eff/JCytol-36-48-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef1/6343391/4a8163e5e3cc/JCytol-36-48-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef1/6343391/bf0725d49eff/JCytol-36-48-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef1/6343391/4a8163e5e3cc/JCytol-36-48-g002.jpg

相似文献

1
Histopathological Review of Diagnostic Categories of the Bethesda System for Reporting Thyroid Cytopathology - An Institutional Experience of 5 Years.甲状腺细胞病理学报告的贝塞斯达系统诊断类别的组织病理学回顾——五年机构经验
J Cytol. 2019 Jan-Mar;36(1):48-52. doi: 10.4103/JOC.JOC_64_18.
2
A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience.关于甲状腺细胞病理学报告的贝塞斯达系统不同诊断类别的恶性率研究:一项机构经验。
Biomed J. 2015 Dec;38(6):517-22. doi: 10.1016/j.bj.2015.08.001. Epub 2016 Mar 9.
3
Unveiling Variations: A Comprehensive Comparison of Five Globally Used Thyroid Cytology Reporting Systems With Histopathological Correlation.揭示差异:五种全球常用甲状腺细胞病理学报告系统与组织病理学相关性的全面比较
Cureus. 2024 Feb 1;16(2):e53359. doi: 10.7759/cureus.53359. eCollection 2024 Feb.
4
Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) - An 8-year tertiary center experience in Thailand.根据《甲状腺细胞病理学报告贝塞斯达系统》(TBSRTC)分类的发病率和恶性率——泰国一家三级中心的8年经验
J Clin Transl Endocrinol. 2018 Dec 14;16:100175. doi: 10.1016/j.jcte.2018.12.004. eCollection 2019 Jun.
5
Reproducibility of "The Bethesda System for Reporting Thyroid Cytopathology:" A Retrospective Analysis of 107 Patients.《贝塞斯达甲状腺细胞病理学报告系统》的可重复性:对107例患者的回顾性分析
J Cytol. 2018 Jan-Mar;35(1):33-36. doi: 10.4103/JOC.JOC_215_16.
6
Reproducibility of Cytomorphological Diagnosis and Assessment of Risk of Malignancy of Thyroid Nodules Based on the Bethesda System for Reporting Thyroid Cytopathology: A Tertiary Cancer Center Perspective.基于甲状腺细胞病理学报告的贝塞斯达系统的甲状腺结节细胞形态学诊断的可重复性及恶性风险评估:三级癌症中心视角
J Microsc Ultrastruct. 2022 Dec 1;10(4):174-179. doi: 10.4103/jmau.jmau_88_21. eCollection 2022 Oct-Dec.
7
Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.应用贝塞斯达系统报告甲状腺细胞病理学用于甲状腺结节分类:不丹人群的临床和细胞病理学特征。
Diagn Cytopathol. 2021 Nov;49(11):1179-1187. doi: 10.1002/dc.24843. Epub 2021 Jul 28.
8
Thyroid cytopathology reporting by the bethesda system: a two-year prospective study in an academic institution.甲状腺细胞病理学的贝塞斯达系统报告:在一所学术机构进行的为期两年的前瞻性研究。
Patholog Res Int. 2015;2015:240505. doi: 10.1155/2015/240505. Epub 2015 Jan 22.
9
Study of Fine Needle Aspiration Cytology (FNAC) of Thyroid Gland According to the Bethesda System.根据贝塞斯达系统对甲状腺细针穿刺细胞学(FNAC)的研究。
Cureus. 2023 Apr 10;15(4):e37371. doi: 10.7759/cureus.37371. eCollection 2023 Apr.
10
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).非侵袭性滤泡性甲状腺肿瘤伴乳头状核特征(NIFTP):对甲状腺细胞病理学报告的 Bethesda 系统(TBSRTC)中恶性肿瘤风险(ROM)的影响。
Cancer Cytopathol. 2018 Jan;126(1):20-26. doi: 10.1002/cncy.21926. Epub 2017 Sep 20.

引用本文的文献

1
Hemithyroidectomy, does the indication influence the outcome?甲状腺次全切除术,适应证是否影响手术结果?
Langenbecks Arch Surg. 2023 Dec 7;409(1):1. doi: 10.1007/s00423-023-03168-w.
2
Incidence and Malignancy Rates in Thyroid Nodules in North-East Indian Population by Bethesda System: A Single Institutional Experience of 3 Years.基于贝塞斯达系统的印度东北部人群甲状腺结节的发病率及恶性率:一项为期3年的单机构研究经验
South Asian J Cancer. 2022 Nov 2;12(2):166-172. doi: 10.1055/s-0042-1757776. eCollection 2023 Apr.
3
Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodules.

本文引用的文献

1
Bethesda System for Reporting Thyroid Cytopathology: A three-year study at a tertiary care referral center in Saudi Arabia.《甲状腺细胞病理学报告的贝塞斯达系统:沙特阿拉伯一家三级医疗转诊中心的三年研究》
World J Clin Oncol. 2017 Apr 10;8(2):151-157. doi: 10.5306/wjco.v8.i2.151.
2
Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting.采用甲状腺细胞病理学贝塞斯达报告系统对甲状腺结节进行细针穿刺活检:农村地区的机构经验
Int J Endocrinol. 2017;2017:9601735. doi: 10.1155/2017/9601735. Epub 2017 Feb 9.
3
Evaluation of indeterminate thyroid cytology by second-opinion diagnosis or repeat fine-needle aspiration: which is the best approach?
一氧化氮、甲状腺球蛋白和降钙素:揭开甲状腺结节的本质。
Front Endocrinol (Lausanne). 2023 Sep 28;14:1241223. doi: 10.3389/fendo.2023.1241223. eCollection 2023.
4
The diversities in thyroid cytopathology practices among Asian countries using the Bethesda system for reporting thyroid cytopathology.亚洲国家在使用甲状腺细胞病理学贝塞斯达报告系统时甲状腺细胞病理学实践的差异。
Gland Surg. 2020 Oct;9(5):1735-1746. doi: 10.21037/gs-20-404.
通过二次诊断或重复细针穿刺评估甲状腺细胞病理学检查结果不确定的情况:哪种方法最佳?
Acta Cytol. 2015;59(1):43-50. doi: 10.1159/000369332. Epub 2015 Jan 17.
4
The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.意义不明确的非典型性/滤泡性病变及重复细针穿刺活检的影响:贝塞斯达系统实施前后5年
Cancer Cytopathol. 2014 Dec;122(12):866-72. doi: 10.1002/cncy.21468. Epub 2014 Jul 30.
5
Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy?根据贝塞斯达系统对甲状腺细针穿刺抽吸活检(FNA)进行回顾性分类的结果:这会提高准确性吗?
Cytopathology. 2015 Aug;26(4):231-7. doi: 10.1111/cyt.12171. Epub 2014 Jul 30.
6
Reporting thyroid FNA before and after implementation of the Bethesda system-one institution's experience.贝塞斯达系统实施前后甲状腺细针穿刺活检报告——一家机构的经验
Diagn Cytopathol. 2015 Jan;43(1):28-31. doi: 10.1002/dc.23182. Epub 2014 May 27.
7
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).甲状腺结节分类为贝塞斯达Ⅲ类(不典型/意义未明的滤泡性病变)的恶性率。
Thyroid. 2014 May;24(5):832-9. doi: 10.1089/thy.2013.0317. Epub 2014 Mar 10.
8
'Suspicious for papillary thyroid carcinoma' before and after The Bethesda System for Reporting Thyroid Cytopathology: impact of standardized terminology.《甲状腺细胞病理学报告贝塞斯达系统》前后的“疑似甲状腺乳头状癌”:标准化术语的影响
Acta Cytol. 2014;58(1):15-22. doi: 10.1159/000355696. Epub 2013 Nov 1.
9
The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up.甲状腺细针穿刺抽吸物报告的贝塞斯达系统:一项有组织学随访的细胞学研究。
J Cytol. 2013 Apr;30(2):94-9. doi: 10.4103/0970-9371.112650.
10
The bethesda system for reporting thyroid cytopathology: a five-year retrospective review of one center experience.甲状腺细胞病理学报告的贝塞斯达系统:一个中心五年回顾性研究经验
Int J Health Sci (Qassim). 2012 Jun;6(2):159-73. doi: 10.12816/0005991.